Member Login

 
Forgot password/Login issues?
Not a Member? Learn more.
  • Blog
  • Partnership
  • Contact
  • Cart (0)
  • Member Login
BCC Research
BCC Research
  • Member Login
  • Solution
    • Membership Membership
      • Academic
      • Corporate
    • Market Research
    • Custom Research
    • Company Index
    • Scorecard
  • Industries Industries
    • Life Sciences Life Sciences
      • Med Devices & Surgical
      • Cell Biology
      • Pharmaceuticals
      • Health Maintenance
    • Digital World Digital World
      • Instrumentation & Sensors
      • Safety and Security
      • Engineering
      • Photonics
      • Information Technology
    • Materials Materials
      • Advanced Materials
      • Plastics
      • Chemicals
      • Semiconductor
      • Nanotechnology
    • Energy & Sustainability Energy & Sustainability
      • Water-Membrane and Separations
      • Fuel Cell and Battery
      • Food
      • Energy
      • Manufacturing
      • Environment
  • Resources Resources
    • Blog
    • e-Course
    • Spotlights Library
    • Megatrends
    • Association Exclusives
    • Partnership
    • Market Research Studies
  • About
    • About BCC Research
    • Press Releases
    • Events
    • Careers
    • Contact
  • Beacon SearchBeacon Search

Or Ask your question to the BCC Research BEACON Beacon Research

  1. Company Index
  2. AbbVie Inc.
  3. News

AbbVie Inc.

  • Overview
  • Financial
  • In Reports
  • Products
  • History
  • Point of Contacts
  • News

In News

AbbVie to Acquire Capstan Therapeutics for $2.1B, Boosting Autoimmune Pipeline - Yahoo Finance

Yahoo Finance - Jul 08, 2025

How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results? - The Globe and Mail

The Globe and Mail - Jul 08, 2025

Pfizer and AbbVie Advance Pediatric Infection Study with ATM-AVI - TipRanks

TipRanks - Jul 08, 2025

Here's What To Expect From AbbVie's Next Earnings Report - Barchart.com

Barchart.com - Jul 07, 2025

AbbVie: Q2 Earnings Warning Reflects Poor R&D, But It's Not A Red Flag (NYSE:ABBV) - Seeking Alpha

Seeking Alpha - Jul 04, 2025

AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Yahoo Finance - Jul 07, 2025

AbbVie to buy Capstan for up to $2.1 billion in immunology push - Reuters

Reuters - Jun 30, 2025

AbbVie Reports First-Quarter 2025 Financial Results - PR Newswire

PR Newswire - Apr 25, 2025

AbbVie to Acquire Capstan Therapeutics for $2 Billion - CHEManager

CHEManager - Jul 03, 2025

AbbVie updates 2025 earnings guidance to reflect $823 million IPR&D expense - Investing.com

Investing.com - Jul 03, 2025

AbbVie sees negative Q2, full-year impact from IPR&D and milestones expense - Seeking Alpha

Seeking Alpha - Jul 03, 2025

US FDA approves AbbVie's drug for a type of lung cancer - Reuters

Reuters - May 14, 2025

BCC Research Beacon
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Thank you for your interest in BCC Research. You will be added to our mailing list.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact
  • 781-489-7301
  • info@bccresearch.com

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions

Please select categories of interest:

Check All